首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   17966篇
  免费   1122篇
  国内免费   98篇
耳鼻咽喉   211篇
儿科学   536篇
妇产科学   424篇
基础医学   2169篇
口腔科学   349篇
临床医学   1731篇
内科学   3939篇
皮肤病学   491篇
神经病学   1570篇
特种医学   619篇
外科学   2243篇
综合类   210篇
一般理论   13篇
预防医学   1823篇
眼科学   286篇
药学   1326篇
中国医学   55篇
肿瘤学   1191篇
  2023年   83篇
  2022年   170篇
  2021年   505篇
  2020年   228篇
  2019年   464篇
  2018年   557篇
  2017年   351篇
  2016年   371篇
  2015年   430篇
  2014年   643篇
  2013年   832篇
  2012年   1059篇
  2011年   1138篇
  2010年   637篇
  2009年   640篇
  2008年   952篇
  2007年   1060篇
  2006年   1033篇
  2005年   1091篇
  2004年   1055篇
  2003年   987篇
  2002年   928篇
  2001年   445篇
  2000年   467篇
  1999年   419篇
  1998年   187篇
  1997年   157篇
  1996年   154篇
  1995年   111篇
  1994年   95篇
  1993年   99篇
  1992年   212篇
  1991年   159篇
  1990年   167篇
  1989年   141篇
  1988年   142篇
  1987年   126篇
  1986年   114篇
  1985年   102篇
  1984年   85篇
  1983年   60篇
  1982年   40篇
  1981年   35篇
  1979年   57篇
  1978年   30篇
  1977年   29篇
  1976年   32篇
  1975年   44篇
  1974年   43篇
  1972年   28篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Breast pseudoaneurysms after a core needle biopsy are a rare complication with a low incidence. However, it is important to be aware of the possibility of complications that require treatment.  相似文献   
2.
3.
4.
ABSTRACT

Measuring hope reliably and accurately remains an important research objective, not least in less prosperous settings where ‘holding on to hope’ may be critically important in the struggle against adverse life conditions. The State Hope Scale was designed for use in the US. Despite reported application in diverse cultures and using translations the scale has not been extensively validated outside US populations. This study contributes to a larger project exploring the measurement of hope and provides a critique of Snyder’s scale as used in a Tanzanian female population of 1021 urban microfinance participants. We evaluate the scale’s validity through assessment of the empirical distribution of scores, item response profiles, internal consistency and discriminatory ability. Participants mostly scored very high and many reached very near the maximum attainable score. Hardly any endorsed the negative half of the response scale. Several problems are discussed including poor discrimination and strong evidence of acquiescence response bias. We also found little association of the scale scores with hypothesised correlates of hope. Future improvements on the measurement of hope are recommended, especially in studies outside the narrow Western context in which the scale was devised.  相似文献   
5.
6.
7.
8.

Background

Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.

Objectives

To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.

Methods

Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.

Results

Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.

Conclusions

These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号